Author details

Full Name

Donna Neuberg

Affiliation

ORCID

Career Start Year

1989

Papers

648

H Index

130

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38052038	Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.	Blood Adv	2024
36720856	Enhancing CAR-T cell functionality in a patient-specific manner.		2023
36183283	Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease.	Int J Hematol	2023
36270432	Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials.	Transplantation and Cellular Therapy	2023
36332187	Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naÃ¯ve settings.	Blood	2023
35994632	Absolute neutrophil count by Duffy status among healthy Black and African American adults.	Blood advances	2023
36322094	Pagophagia and restless legs syndrome are highly associated with iron deficiency and should be included in histories evaluating anemia.	American Journal of Hematology	2023
37756539	Influence of thrombocytopenia on bleeding and vascular events in atrial fibrillation.		2023
37738974	ZNF683 marks a CD8<sup>+</sup> TÂ cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.	Cancer Cell	2023
37580396	Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.		2023
37552303	Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.		2023
36577290	Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantation.	Leuk Res	2023
36508268	Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia.	Blood Adv	2023
37461125	Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.		2023
36706355	Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.	Blood	2023
37013955	Correcting the record on anemia of aging: a statistical reanalysis.		2023
37319437	Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.	Blood	2023
36477552	Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models.		2023
36624313	Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.	Nat Med	2023
37369986	Impact of cytoreduction and remission status on hematopoietic cell transplantation outcomes in pediatric myelodysplastic syndrome and related disorders.	Pediatr Blood Cancer	2023
37115512	Clonal Hematopoiesis in Young Women Treated for Breast Cancer.		2023
36740041	Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors.	J Thromb Haemost	2023
36469010	Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor Models.	Cancer Research	2023
36468984	In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities.	Blood Cancer Discov	2023
37432068	Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.	Blood Adv	2023
36607804	Persistence of Unequal Access to Classical Hematology Telemedicine Visits by Race and Other Demographics During the COVID-19 Pandemic.		2023
36534523	Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates.	Clin Cancer Res	2023
37483562	Prediction of risk for myeloid malignancy in clonal hematopoiesis.	NEJM Evid	2023
37163357	FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged â¿¥60 years.	Blood Adv	2023
35086145	Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors.	Blood Adv	2022
35846042	A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies.		2022
35775490	Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma.	J Clin Invest	2022
35714308	TET2-mutant clonal hematopoiesis and risk of gout.	Blood	2022
35903706	Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia.	Front Oncol	2022
35902743	Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment.	Nat Genet	2022
35766906	Peripheral blood CD3<sup>+</sup> T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies.	Br J Haematol	2022
36096050	Clonal hematopoiesis of indeterminate potential andÂ risk of death from COVID-19.	Blood	2022
35508657	Landscape of helper and regulatory antitumour CD4<sup>+</sup> T cells in melanoma.	Nature	2022
35443043	Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer.	Clinical Cancer Research	2022
35613184	Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study.	PLoS Med	2022
35549298	Immune recall improves antibody durability and breadth to SARS-CoV-2 variants.	Science immunology	2022
36129839	Patient perspectives on testing for clonal hematopoiesis ofÂ indeterminate potential.	Blood Adv	2022
35927489	Molecular map of chronic lymphocytic leukemia and its impact on outcome.	Nat Genet	2022
35316569	Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.	Pediatric Blood and Cancer	2022
34855941	Association of clonal hematopoiesis with chronic obstructive pulmonary disease.	Blood	2022
35289704	Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax.	Leuk Lymphoma	2022
34507355	Genomic profiling of a randomized trial of interferon-Î± vs hydroxyurea in MPN reveals mutation-specific responses.	Blood advances	2022
35217807	Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients.	Leukemia	2022
35020831	Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib.	Blood	2022
35081257	Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy.	Blood Adv	2022